EXOZYMES INC. (EXOZ) Form 10-K Annual Reports
EXOZYMES INC. (EXOZ) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: EXOZ
CIK: 2010788
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
RBSM LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerMARLENE HUTCHESON
Audit LocationLAS VEGAS, Nevada, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-09 | 2026-10-09 | 8-K | 0001493152-26-046456 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-28 | — | DEFA14A | 0001140361-26-037860 | View SEC Doc Filr Page |
| DEF 14A | 2026-09-28 | 2026-11-13 | DEF 14A | 0001140361-26-037859 | View SEC Doc Filr Page |
| 8-K | 2026-09-18 | 2026-09-17 | 8-K | 0001493152-26-043288 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-14 | 4 | 0001493152-26-043174 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-19 | 4 | 0001493152-26-041290 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-19 | 4 | 0001493152-26-040129 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-19 | 4 | 0001493152-26-040116 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001493152-26-037725 | View SEC Doc Filr Page |
| 8-K | 2026-07-01 | 2026-06-30 | 8-K | 0001493152-26-031560 | View SEC Doc Filr Page |
| 424B5 | 2026-06-30 | — | 424B5 | 0001493152-26-031284 | View SEC Doc Filr Page |
| 8-K | 2026-06-26 | 2026-06-25 | 8-K | 0001493152-26-030205 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-17 | 8-K | 0001493152-26-029119 | View SEC Doc Filr Page |
| 8-K | 2026-06-08 | 2026-06-05 | 8-K | 0001493152-26-027688 | View SEC Doc Filr Page |
| 424B5 | 2026-06-08 | — | 424B5 | 0001493152-26-027611 | View SEC Doc Filr Page |
| 424B5 | 2026-06-04 | — | 424B5 | 0001493152-26-027208 | View SEC Doc Filr Page |
| 424B5 | 2026-05-29 | — | 424B5 | 0001493152-26-025698 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001493152-26-023035 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | 8-K | 0001493152-26-021589 | View SEC Doc Filr Page |
| 8-K | 2026-04-10 | 2026-04-10 | 8-K | 0001493152-26-016227 | View SEC Doc Filr Page |
| 4 | 2026-04-10 | 2026-04-09 | 4 | 0001493152-26-016166 | View SEC Doc Filr Page |
| 424B5 | 2026-04-09 | — | 424B5 | 0001493152-26-015919 | View SEC Doc Filr Page |
| 4 | 2026-04-08 | 2026-04-01 | 4 | 0001493152-26-015761 | View SEC Doc Filr Page |
| 3 | 2026-04-08 | 2026-04-01 | 3 | 0001493152-26-015759 | View SEC Doc Filr Page |
| 4 | 2026-04-08 | 2026-04-01 | 4 | 0001493152-26-015630 | View SEC Doc Filr Page |